Terns Pharmaceuticals, Inc.
Healthcare · Biotechnology · $4.77B market cap · Ranked #32 of 1,201
Scores well above the universe median on the composite. Ranks in the 97th percentile overall.
Figures come straight from the company’s filed quarterly report and feed the six-factor model (growth, quality, and value especially). This is a summary of what was reported — research, not a recommendation, and there are no analyst estimates behind it, so it isn’t a beat-or-miss call.
The latest raw values feeding the six factors.
Every rating we’ve ever assigned TERN — append-only and hash-verified. We don’t revise or delete past calls.
1 rating change across 37 snapshots — each with the factor shift that drove it.
The full append-only record of every call we’ve made on TERN— the accountability history mainstream sites quietly edit and we can’t — is part of Proofstock Plus.
Unlock with Plus